TipRanks
Fuse Medical Inc (FZMD)
OTHER OTC:FZMD
US Market
FZMD
Fuse Medical
RESEARCH TOOLSreports
Want to see FZMD full AI Analyst Report?

Fuse Medical (FZMD) Ratios

8 Followers

Fuse Medical Ratios

FZMD's free cash flow for Q2 2023 was $0.69. For the 2023 fiscal year, FZMD's free cash flow was decreased by $ and operating cash flow was $0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Mar 23
Liquidity Ratios
Current Ratio
 1.88 1.88 1.42 1.17 1.11
Quick Ratio
 0.40 0.40 0.33 0.32 0.34
Cash Ratio
 0.06 0.06 0.03 0.02 0.01
Solvency Ratio
 0.05 0.05 0.09 0.11 0.16
Operating Cash Flow Ratio
 0.03 0.03 -0.02 0.04 <0.01
Short-Term Operating Cash Flow Coverage
 0.09 0.09 -0.07 0.25 0.02
Net Current Asset Value
$ 4.05M$ 4.05M$ 2.97M$ -2.52M$ -6.31M
Leverage Ratios
Debt-to-Assets Ratio
 0.20 0.20 0.15 0.12 0.12
Debt-to-Equity Ratio
 0.39 0.39 0.34 1.73 -7.55
Debt-to-Capital Ratio
 0.28 0.28 0.25 0.63 1.15
Long-Term Debt-to-Capital Ratio
 0.03 0.03 0.03 0.15 -1.80
Financial Leverage Ratio
 1.91 1.91 2.20 14.15 -63.58
Debt Service Coverage Ratio
 0.26 0.26 0.40 0.90 1.47
Interest Coverage Ratio
 2.13 2.13 3.76 1.74 -4.76
Debt to Market Cap
 1.02 1.49 0.42 0.24 0.22
Interest Debt Per Share
 0.04 0.04 0.03 0.03 0.04
Net Debt to EBITDA
 4.14 4.14 2.29 0.96 0.64
Profitability Margins
Gross Profit Margin
71.95%71.95%64.01%66.61%61.90%
EBIT Margin
4.25%4.25%6.73%10.57%17.66%
EBITDA Margin
6.10%6.10%8.21%11.39%18.40%
Operating Profit Margin
4.25%4.25%6.73%2.38%-4.37%
Pretax Profit Margin
1.66%1.66%4.94%9.20%16.74%
Net Profit Margin
1.52%1.52%4.79%9.06%16.62%
Continuous Operations Profit Margin
1.52%1.52%4.79%9.06%16.62%
Net Income Per EBT
91.26%91.26%97.06%98.44%99.24%
EBT Per EBIT
39.09%39.09%73.40%386.43%-383.03%
Return on Assets (ROA)
1.06%1.06%3.54%8.98%15.68%
Return on Equity (ROE)
2.05%2.03%7.79%127.05%-996.61%
Return on Capital Employed (ROCE)
5.15%5.15%10.57%6.93%-11.05%
Return on Invested Capital (ROIC)
3.75%3.75%7.95%5.15%-8.49%
Return on Tangible Assets
1.14%1.14%3.79%9.61%18.66%
Earnings Yield
6.95%9.73%9.75%17.30%29.37%
Efficiency Ratios
Receivables Turnover
 5.40 5.40 4.85 5.26 4.66
Payables Turnover
 3.72 3.72 2.51 2.33 1.25
Inventory Turnover
 0.31 0.31 0.46 0.59 0.75
Fixed Asset Turnover
 254.73 254.73 151.44 0.00 26.30K
Asset Turnover
 0.70 0.70 0.74 0.99 0.94
Working Capital Turnover Ratio
 2.26 2.26 4.23 9.92 8.75
Cash Conversion Cycle
 1.13K 1.13K 722.89 531.28 273.22
Days of Sales Outstanding
 67.56 67.56 75.24 69.45 78.24
Days of Inventory Outstanding
 1.16K 1.16K 793.06 618.50 487.89
Days of Payables Outstanding
 98.02 98.02 145.41 156.66 292.92
Operating Cycle
 1.23K 1.23K 868.30 687.94 566.14
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 <0.01 >-0.01 <0.01 <0.01
Free Cash Flow Per Share
 <0.01 <0.01 >-0.01 0.00 <0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 0.79 0.79 1.48 0.00 1.00
Dividend Paid and CapEx Coverage Ratio
 4.88 4.88 -2.10 1.00 0.00
Capital Expenditure Coverage Ratio
 4.88 4.88 -2.10 1.00 0.00
Operating Cash Flow Coverage Ratio
 0.07 0.07 -0.07 0.22 0.01
Operating Cash Flow to Sales Ratio
 0.02 0.02 -0.01 0.03 <0.01
Free Cash Flow Yield
6.64%9.76%-4.16%0.00%0.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 14.00 10.00 10.26 5.78 3.40
Price-to-Sales (P/S) Ratio
 0.23 0.16 0.49 0.52 0.57
Price-to-Book (P/B) Ratio
 0.29 0.21 0.80 7.34 -33.93
Price-to-Free Cash Flow (P/FCF) Ratio
 15.07 10.24 -24.03 0.00 303.12
Price-to-Operating Cash Flow Ratio
 11.40 8.14 -35.50 19.02 303.12
Price-to-Earnings Growth (PEG) Ratio
 0.02 -0.14 -0.16 -0.11 -0.01
Price-to-Fair Value
 0.29 0.21 0.80 7.34 -33.93
Enterprise Value Multiple
 7.90 6.69 8.27 5.56 3.72
Enterprise Value
 4.35M 3.69M 7.28M 10.19M 12.75M
EV to EBITDA
 7.90 6.69 8.27 5.56 3.72
EV to Sales
 0.48 0.41 0.68 0.63 0.68
EV to Free Cash Flow
 31.67 26.84 -33.22 0.00 366.32
EV to Operating Cash Flow
 25.17 21.34 -49.07 22.97 366.32
Tangible Book Value Per Share
 0.08 0.08 0.08 <0.01 -0.05
Shareholders’ Equity Per Share
 0.10 0.10 0.09 0.02 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.09 0.09 0.03 0.02 <0.01
Revenue Per Share
 0.13 0.13 0.15 0.23 0.27
Net Income Per Share
 <0.01 <0.01 <0.01 0.02 0.04
Tax Burden
 0.91 0.91 0.97 0.98 0.99
Interest Burden
 0.39 0.39 0.73 0.87 0.95
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.68 0.68 0.57 0.00 0.35
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 1.26 1.26 -0.29 0.30 0.01
Currency in USD